Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • Africa
  • Afrique

Categories

  • ABB
  • Alps
  • Basel
  • Bern
  • Chubb
  • Geneva
  • Glencore
  • Lausanne
  • Nestlé
  • Novartis
  • Roche
  • Switzerland
  • UBS
  • Vitol
  • Zürich
  • Zurich Insurance
Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • Africa
  • Afrique

Browsing Tag

IL-33

3 posts
RRoche
Qyuns and Roche partner in $1B+ bispecific antibody deal
Read More

Qyuns and Roche partner in $1B+ bispecific antibody deal

  • 2026-03-03
To read the full story, subscribe or sign in. Oct. 29, 2025 By Marian (YoonJee) Chu No Comments…
RRoche
Qyuns and Roche partner in $1B+ bispecific antibody deal
Read More

Qyuns and Roche partner in $1B+ bispecific antibody deal

  • 2026-03-03
To read the full story, subscribe or sign in. Nov. 4, 2025 By Marian (YoonJee) Chu No Comments…
RRoche
Still no scare for Ohtuvayre: Roche IL-33 COPD data mixed
Read More

Still no scare for Ohtuvayre: Roche IL-33 COPD data mixed

  • 2026-03-02
The fate of IL-33-targeting astegolimab will be determined by talks with regulators, after Roche AG’s Genentech unit rolled…
Switzerland
www.europesays.com